Literature DB >> 11671410

Total Synthesis of Dehydrodidemnin B. Use of Uronium and Phosphonium Salt Coupling Reagents in Peptide Synthesis in Solution.

Gemma Jou1, Isabel González, Fernando Albericio, Paul Lloyd-Williams, Ernest Giralt.   

Abstract

New total syntheses of didemnin A and of dehydrodidemnin B are described. The latter didemnin has the highest antiproliferative activity of all members of this family of macrocyclic depsipeptides. It was produced on coupling the side chain Pyr-Pro-OH to didemnin A, which was itself synthesized by two novel routes. One of these was based on the elaboration of a linear heptadepsipeptide incorporating the first amino acid of the didemnin side chain, (R)-N(Me)-Leu. Deprotection of the amino and carboxyl terminii of this linear precursor followed by macrocyclization gave a protected derivative of didemnin A. The second route involved synthesis of the Boc-protected didemnin macrocycle from a linear hexadepsipeptide lacking (R)-N(Me)-Leu. Removal of the Boc group from the macrocycle followed by its coupling with Boc-(R)-N(Me)-Leu-OH then gave Boc-didemnin A. The overall yield was much higher for the second strategy (27% compared to 4% for the first synthesis), but both allowed synthetic didemnin A, identical with a natural sample, to be prepared. Extensive use was made of phosphonium and uronium salt-based coupling reagents, such as BOP, PyBrOP, PyAOP, HBTU, and HATU for the formation of both the secondary and tertiary amide bonds present in these complex depsipeptides.

Entities:  

Year:  1997        PMID: 11671410     DOI: 10.1021/jo961932h

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  10 in total

1.  Total synthesis of Lys(3) tamandarin M: a potential affinity ligand.

Authors:  Kenneth M Lassen; Madeleine M Joullié
Journal:  Org Lett       Date:  2010-10-29       Impact factor: 6.005

2.  Synthetic studies of tamandarin B side chain analogues.

Authors:  Kenneth M Lassen; Jisun Lee; Madeleine M Joullié
Journal:  J Org Chem       Date:  2010-05-07       Impact factor: 4.354

3.  Bacterial biosynthesis and maturation of the didemnin anti-cancer agents.

Authors:  Ying Xu; Roland D Kersten; Sang-Jip Nam; Liang Lu; Abdulaziz M Al-Suwailem; Huajun Zheng; William Fenical; Pieter C Dorrestein; Bradley S Moore; Pei-Yuan Qian
Journal:  J Am Chem Soc       Date:  2012-04-06       Impact factor: 15.419

4.  An efficient synthesis of the tamandarin B macrocycle.

Authors:  Kenneth M Lassen; Jisun Lee; Madeleine M Joullié
Journal:  Tetrahedron Lett       Date:  2010-03-31       Impact factor: 2.415

5.  Discovery of thioether-bridged cyclic pentapeptides binding to Grb2-SH2 domain with high affinity.

Authors:  Sheng Jiang; Chenzhong Liao; Lakshman Bindu; Biaolin Yin; Karen W Worthy; Robert J Fisher; Terrence R Burke; Marc C Nicklaus; Peter P Roller
Journal:  Bioorg Med Chem Lett       Date:  2009-03-29       Impact factor: 2.823

6.  The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipains.

Authors:  Sara Christina Stolze; Edgar Deu; Farnusch Kaschani; Nan Li; Bogdan I Florea; Kerstin H Richau; Tom Colby; Renier A L van der Hoorn; Hermen S Overkleeft; Matthew Bogyo; Markus Kaiser
Journal:  Chem Biol       Date:  2012-12-21

Review 7.  "Head-to-side-chain" cyclodepsipeptides of marine origin.

Authors:  Marta Pelay-Gimeno; Judit Tulla-Puche; Fernando Albericio
Journal:  Mar Drugs       Date:  2013-05-21       Impact factor: 5.118

8.  Synthesis of 2-(4,6-dimethoxy-1,3,5-triazin-2-yloxyimino) derivatives: application in solution peptide synthesis.

Authors:  Tarfah I Al-Warhi; Hassan M A Al-Hazimi; Ayman El-Faham; Fernando Albericio
Journal:  Molecules       Date:  2010-12-20       Impact factor: 4.411

Review 9.  Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development.

Authors:  David J Newman; Gordon M Cragg
Journal:  Mar Drugs       Date:  2014-01-14       Impact factor: 5.118

Review 10.  Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the "Supply Problem".

Authors:  Nelson G M Gomes; Ramesh Dasari; Sunena Chandra; Robert Kiss; Alexander Kornienko
Journal:  Mar Drugs       Date:  2016-05-21       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.